Table 5.
“I think I am” scores
| “I think I am” score | Baseline score (n) | Endpoint score | ||||
|---|---|---|---|---|---|---|
| Mean (SD) | LS mean change from baseline (SE) | Difference in LS means | ||||
| Atomoxetine (N = 49) | Placebo (N = 50) | Atomoxetine (N = 49) | Placebo (N = 50) | Estimate (95% CI) | P value | |
| Total score | 39 | 34 | 0.28 (0.25) | 0.13 (0.26) | 0.15 (−0.55; 0.85) | 0.671 |
| 4.97 (1.63) | 4.85 (1.74) | |||||
| L-scale total | 12 | 13 | 0.63 (0.58) | 0.01 (0.57) | 0.62 (−1.05; 2.29) | 0.438 |
| 5.33 (1.87) | 5.31 (1.97) | |||||
| MH-scale total | 27 | 21 | 0.10 (0.23) | 0.31 (0.27) | −0.21 (−0.92; 0.50) | 0.553 |
| 4.81 (1.52) | 4.57 (1.57) | |||||
| MH-scale domains | ||||||
| Physical abilities | 31 | 27 | −0.51 (0.27) | −0.52 (0.28) | 0.02 (−0.75; 0.79) | 0.960 |
| 5.42 (1.84) | 5.67 (2.02) | |||||
| Performance | 29 | 26 | 0.32 (0.24) | −0.22 (0.27) | 0.53 (−0.19; 1.26) | 0.147 |
| 4.66 (1.97) | 5.46 (1.65) | |||||
| Physical well-being | 31 | 29 | 0.76 (0.24) | 0.24 (0.25) | 0.52) (−0.17; 1.20 | 0.137 |
| 3.77 (1.54) | 3.59 (1.74) | |||||
| Family relations | 30 | 29 | −0.29 (0.31) | 0.08 (0.32) | −0.37 (−1.25; 0.51) | 0.398 |
| 4.53 (1.94) | 4.52 (1.90) | |||||
| Relation to peers | 28 | 26 | −0.14 (0.30) | 0.10 (0.32) | −0.24 (−1.12; 0.64) | 0.590 |
| 5.54 (1.91) | 4.77 (1.95) | |||||
Baseline and change from baseline to endpoint
L-scale children 7–10 years, MH-scale children 11–16 years, n number of evaluable patients, N maximum number of patients, SD standard deviation, LS least square, SE standard error, CI confidence interval